Source: Network Newswire

Press Release: Soluble Therapeutics : Predictive Oncology Inc. (NASDAQ: POAI) Announces Acquisition of Soluble Therapeutics, BioDtech as it Continues Buildout of Precision Medicine Business - NetworkNewsWire

Predictive Oncology announced the acquisition of Soluble Therapeutics Inc. & BioDtech Inc. Acquired companies seek to enhance drug development process through the optimization of protein solubility and stability as well as through detection, removal of endotoxins The companies were acquired for consideration amounting to 125,000 common shares and waiving of $1.07 million promissory note issued ... Continue reading "Predictive Oncology Inc. (NASDAQ: POAI) Announces Acquisition of Soluble Therapeutics, BioDtech as it Continues Buildout of Precision Medicine Business"

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Joseph Garner's photo - CEO of Soluble Therapeutics

CEO

Joseph Garner

CEO Approval Rating

69/100

Read more